Nivolumab or Nivolumab Plus Cisplatin, in Combination with Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

STUDY BASICS

Have you been diagnosed with locally advanced squamous cell carcinoma of the head and neck? If so, you may be eligible to participate in a study to help researchers compare combinations of treatments to see how well the combinations work along with their safety and tolerability. Participants will be randomly assigned (like the flip of a coin) into one of two treatment arms.